Year: 2015
Type: article
Abstract: ASXL2 is an ETP family protein that interacts with PPARγ. We find that ASXL2-/- mice are insulin resistant, lipodystrophic, and fail to respond to a high-fat diet. Consistent with genetic variation at the ASXL2 locus and human bone mineral density, ASXL2-/- mice are also severely osteopetrotic because of failed osteoclast differentiation attended by normal bone formation. ASXL2 regulates the osteoclast via two distinct signaling pathways. It induces osteoclast formation in a PPARγ/c-Fos-dependent manner and is required for RANK ligand- and thiazolidinedione-induced bone resorption independent of PGC-1β. ASXL2 also promotes osteoclast mitochondrial biogenesis in a process mediated by PGC-1β but independent of c-Fos. Thus, ASXL2 is a master regulator of skeletal, lipid, and glucose homeostasis.
Source: Cell Reports
Language: English
Topic: Bone Metabolism and Diseases
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,620
Awards: Diabetes Research & Training Center, G2224343595, G303945890, Mechanisms of RANKL Mediated Osteoclast Activation, Mechanisms of AVB3 Integrin Mediated Bone Resorption, Core Center for Musculoskeletal Biology and Medicine, G4780753570, DE NOVO LIPOGENESIS AND METABOLIC DISEASE, G7765683143, Mechanisms of Polarized Secretion by Bone Cells, Osteogenic and Angiogenic Response to Skeletal Loading, G9000012773, Washington University Nutrition Obesity Research Center, Diabetes Research Center
OpenAlex ID: W1496251975
